Malabsorption Syndrome - MD Biochemistry Exam Answer (10 Marks)

Definition

• Sleisenger and Fordtran's Gastrointestinal and Liver Disease, 11th ed.
• Tietz Textbook of Laboratory Medicine, 7th ed., p. 906

Normal Physiology of Digestion and Absorption

1. Luminal phase: Dietary fats, proteins, and carbohydrates are hydrolyzed and solubilized by pancreatic enzymes (lipase, amylase, proteases) and bile salts.
2. Mucosal (brush border) phase: Digested products are transported across the brush border membrane of intestinal enterocytes via specific carrier proteins.
3. Post-absorptive (transport) phase: Lipids are packaged into chylomicrons and transported via intestinal lymphatics and the portal circulation.

• Guyton and Hall Textbook of Medical Physiology, 14th ed., p. 826
• Sleisenger and Fordtran's, block27

Classification and Biochemical Mechanisms

I. Luminal Phase Disorders

A. Defective Lipolysis (Fat Maldigestion)

• Pancreatic exocrine insufficiency (chronic pancreatitis, cystic fibrosis, pancreatic carcinoma) causes reduced secretion of lipase, colipase, amylase, and proteases.
• Fat malabsorption (steatorrhea) appears when pancreatic lipase output falls below 10% of normal secretory values.
• In exocrine pancreatic insufficiency, reduced bicarbonate secretion lowers luminal pH, further inactivating lipase.
• Sleisenger and Fordtran's, Fat Malabsorption, p. 2053
• Schwartz's Principles of Surgery, 11th ed., block16

B. Defective Micelle Formation (Bile Salt Deficiency)

• Reduced synthesis: parenchymal liver disease (cirrhosis, PBC), biliary obstruction
• Intestinal loss: ileal resection, severe ileal mucosal disease (Crohn's disease)
• Luminal deconjugation: small intestinal bacterial overgrowth (SIBO) - bacteria deconjugate primary bile salts, reducing micelle-forming capacity
• Binding: cholestyramine; low luminal pH (Zollinger-Ellison syndrome)
• Sleisenger and Fordtran's, Table 104.2, p. 2053

II. Mucosal Phase Disorders

A. Celiac Disease (Gluten-Sensitive Enteropathy)

• An autoimmune-mediated enteropathy triggered by dietary gluten (found in wheat, rye, and barley) in genetically susceptible individuals (HLA-DQ2 / DQ8 positive).
• Immunological destruction of intestinal enterocytes causes villous atrophy and crypt hyperplasia, reducing the absorptive surface area by up to 2-fold in mild disease; in severe disease, villi are completely blunted.
• Defective uptake of free fatty acids and monoglycerides results from reduced mucosal surface area, reduced enterocyte function, and mucosal inflammation.
• Removal of gluten results in mucosal recovery, usually within weeks in children.
• Guyton and Hall Textbook of Medical Physiology, 14th ed., p. 826
• Sleisenger and Fordtran's, p. 2054
• Cellular and Molecular Immunology, 10th ed.

B. Tropical Sprue

• Common in the tropics; associated with bacterial infections causing mucosal inflammation.
• Treated with antibacterial agents; causes fat, folate, and B12 malabsorption.
• Guyton and Hall, p. 826

C. Carbohydrate Malabsorption

• Lactase deficiency (primary or secondary): inability to hydrolyze lactose into glucose and galactose at the brush border. Undigested lactose passes to the colon, where bacterial fermentation produces short-chain fatty acids and gas, causing osmotic diarrhea, bloating, and flatulence.
• Other disaccharidase deficiencies (sucrase-isomaltase) cause similar osmotic diarrhea.
• Tietz Textbook of Laboratory Medicine, 7th ed., p. 560

D. Abetalipoproteinemia

• Defective synthesis of apoprotein B-48, impairing chylomicron assembly and secretion from enterocytes.
• Fat-soluble vitamins (A, D, E, K) accumulate in enterocytes but cannot be transported.
• Results in acanthocytes, steatorrhea, progressive ataxia, and retinitis pigmentosa.
• Sleisenger and Fordtran's, p. 2054

III. Post-Mucosal (Transport) Phase Disorders

• Lymphatic obstruction: Whipple disease, intestinal lymphangiectasia, lymphoma, tuberculosis, retroperitoneal fibrosis.
• Impaired transport of chylomicrons from intestinal lacteals to the thoracic duct causes fat and fat-soluble vitamin malabsorption.
• Characteristically produces protein-losing enteropathy with hypoalbuminemia.
• Sleisenger and Fordtran's, p. 2055

Biochemical Consequences of Malabsorption

• Sleisenger and Fordtran's, p. 2351-2355; Tietz Textbook of Laboratory Medicine, 7th ed., p. 909-910
• Harrison's Principles of Internal Medicine, 22nd ed. (2025)

Note: In severe fat malabsorption, unabsorbed fatty acids form calcium soaps in the colon, aggravating calcium and magnesium deficiency. Sleisenger and Fordtran's, p. 2053

Biochemical/Laboratory Diagnosis

Screening Tests (Blood)

• CBC: Microcytic anemia (iron deficiency), macrocytic anemia (B12/folate deficiency)
• Serum albumin: Low in protein malabsorption or protein-losing enteropathy
• Serum calcium, magnesium: Low in fat malabsorption
• Serum cholesterol, triglycerides, alpha-carotene: Low levels suggest fat malabsorption
• Prothrombin time: Prolonged in Vitamin K deficiency
• Serum folate, B12, ferritin: Iron and vitamin deficiencies
• Serum alkaline phosphatase: Elevated in osteomalacia

Confirmatory Tests

1. Fecal fat quantification (van de Kamer method): Gold standard. Fecal fat >7 g/day (on 100 g fat/day diet) confirms steatorrhea.
2. Fecal elastase: Low levels (<100 µg/g stool) indicate exocrine pancreatic insufficiency.
3. D-xylose absorption test: Oral xylose absorbed by passive/carrier-mediated mechanisms in the proximal small intestine, independent of pancreatic enzymes. Low urinary xylose excretion indicates mucosal (intestinal) disease.
4. ¹³C-mixed chain triglyceride breath test: Assesses intraluminal pancreatic lipase activity; sensitivity 89%, specificity 81% for pancreatic insufficiency.
5. Hydrogen breath test: For lactase deficiency and SIBO - colonic fermentation produces excess H₂.
6. Serum anti-tissue transglutaminase (anti-tTG IgA) and anti-endomysial antibodies: Specific serological markers for celiac disease.
7. Small intestinal biopsy: Villous atrophy, crypt hyperplasia in celiac disease; PAS-positive macrophages in Whipple disease.
8. Schilling test: Assesses vitamin B12 absorption - differentiates pernicious anemia from terminal ileal disease.

• Tietz Textbook of Laboratory Medicine, 7th ed., pp. 911-917
• Sleisenger and Fordtran's, Table 104.4, p. 2057

Key Conditions with Biochemical Correlates

Short Bowel Syndrome

• Following extensive small bowel resection: reduced absorptive surface area leads to global malabsorption.
• Ileal resection specifically impairs enterohepatic circulation of bile salts and vitamin B12 absorption (intrinsic factor-B12 complex absorbed exclusively in terminal ileum).

Whipple Disease

• Caused by Tropheryma whipplei, a gram-positive actinomycetes.
• PAS-positive macrophages fill the lamina propria, obstructing lymphatic flow.
• Causes fat, fat-soluble vitamin malabsorption, and protein-losing enteropathy.

Crohn's Disease

• Terminal ileal involvement impairs B12 and bile salt absorption.
• Fistulas and SIBO compound malabsorption.

Treatment Principles (Biochemical Basis)

1. Pancreatic enzyme replacement: Oral pancreatin (lipase, amylase, protease) supplements for pancreatic exocrine insufficiency.
2. Gluten-free diet: Complete removal of wheat, rye, and barley for celiac disease; mucosal recovery within weeks.
3. Fat-soluble vitamin replacement: May require parenteral administration in severe fat malabsorption; water-miscible forms (polyethylene glycol succinate vitamin E, hydroxylated vitamin D) for oral use.
4. Vitamin B12 (IM): Bypasses defective ileal absorption in terminal ileal disease or pernicious anemia.
5. Calcium and magnesium supplementation: Corrects deficiency secondary to fatty acid soap formation.
6. Medium-chain triglycerides (MCT): Do not require bile salt micelles or chylomicron formation; absorbed directly into portal circulation - used in severe fat malabsorption.

• Sleisenger and Fordtran's, p. 2355-2357
• Katzung's Basic and Clinical Pharmacology, 16th ed.

References

1. Sleisenger and Fordtran's Gastrointestinal and Liver Disease, 11th Edition (Feldman, Friedman, Brandt). Elsevier. Chapters 104 (Fat Malabsorption), 101 (Malabsorption and Maldigestion).
2. Tietz Textbook of Laboratory Medicine, 7th Edition (Rifai et al., eds). Elsevier, 2023. Chapter 52: Investigation of Maldigestion and Malabsorption, pp. 906-917.
3. Guyton and Hall Textbook of Medical Physiology, 14th Edition (Hall JE). Elsevier. Chapter 65: Malabsorption by the Small Intestinal Mucosa, p. 826.
4. Harrison's Principles of Internal Medicine, 22nd Edition (2025). McGraw-Hill Medical. Section on Malabsorption Syndromes.
5. Goldman-Cecil Medicine, 26th Edition (2023). Elsevier. Chapter on Malabsorption.
6. Yamada's Textbook of Gastroenterology, 7th Edition (2019). Wiley-Blackwell.
7. Robbins and Kumar Basic Pathology, 11th Edition. Elsevier.
8. StatPearls - Malabsorption Syndromes. NCBI Bookshelf. National Library of Medicine (continuously updated, peer-reviewed).